Please check your internet connection and try again.
# Arsil dx (Dextromethorphan/Chlorpheniramine)
## Overview
Arsil DX is a fixed-dose combination product containing Dextromethorphan (a centrally acting antitussive) and Chlorpheniramine (a first-generation sedating antihistamine). It is utilized for the symptomatic management of cough and upper respiratory symptoms.
## Primary Indications
Temporary relief of cough, sneezing, runny nose, and watery eyes associated with the common cold or upper respiratory allergies.
## Adult Dosing
* **Standard dose:** 10–20 mg Dextromethorphan / 2–4 mg Chlorpheniramine every 4–6 hours as needed.
* **Maximum daily dose:** Do not exceed 120 mg Dextromethorphan and 24 mg Chlorpheniramine in a 24-hour period.
## Pediatric Dosing
* **Children 6–12 years:** 5–10 mg Dextromethorphan / 1–2 mg Chlorpheniramine every 4–6 hours as needed. Maximum: 60 mg Dextromethorphan / 12 mg Chlorpheniramine per 24 hours.
* **Children < 6 years:** Generally **not recommended** due to lack of efficacy and safety concerns; consult local pediatric guidelines. Do not use in children < 4 years without medical supervision.
## Dose Adjustments
* **Renal/Hepatic impairment:** No specific universal guidelines exist for this combination. Use caution; lower doses or extended dosing intervals may be required to avoid accumulation of sedating effects.
* **Geriatric:** Start at the lower end of the dosing range due to increased risk of cognitive impairment, urinary retention, and orthostatic hypotension from the antihistamine component.
## Contraindications
* Hypersensitivity to any product component.
* Concomitant use with Monoamine Oxidase Inhibitors (MAOIs) or within 14 days of discontinuing MAOI therapy (risk of serotonin syndrome).
* Narrow-angle glaucoma.
* Symptomatic prostatic hypertrophy or bladder neck obstruction.
## Adverse Effects
* **Dextromethorphan:** Dizziness, drowsiness, nausea, vomiting, and nervousness.
* **Chlorpheniramine:** Significant sedation/drowsiness, dry mouth (xerostomia), blurred vision, constipation, and urinary retention.
* **Serious:** Paradoxical excitation (especially in children), respiratory depression (rare, with overdose).
## Key Drug Interactions
* **MAOIs:** Absolute contraindication; life-threatening serotonin syndrome.
* **CNS Depressants:** Alcohol, benzodiazepines, and opioids increase sedation and respiratory depression risk.
* **CYP2D6 Inhibitors:** SSRIs (e.g., fluoxetine, paroxetine) may significantly increase plasma levels of dextromethorphan.
* **Anticholinergics:** Concurrent use increases risk of constipation, urinary retention, and cognitive impairment.
## Monitoring
* **Efficacy:** Symptom severity and frequency of cough.
* **Safety:** Monitor for CNS effects (excessive sedation), urinary output (especially in elderly males), and blood pressure.
* **Duration:** Discontinue if cough persists > 7 days or is accompanied by high fever or persistent headache.
## Clinical Pearls
* **Sedation Warning:** Highly sedating; counsel patients to avoid driving or operating machinery until the response is known.
* **Alcohol:** Explicitly warn patients to avoid concurrent alcohol use.
* **Combination Cold Products:** Caution patients against taking multiple products containing acetaminophen, dextromethorphan, or antihistamines to prevent unintentional overdose.
* **Efficacy:** Evidence for over-the-counter antitussives in acute cough is limited; hydration and honey (for patients > 1 year) are often preferred first-line interventions.
***
**Educational Disclaimer:** This information is for educational purposes only. Clinical practice guidelines vary by institution and region. Always verify dosages, contraindications, and drug-drug interactions against current institutional protocols, local regulatory prescribing information, or high-fidelity clinical databases (e.g., Lexicomp, Micromedex) before administration.
